|
Clinicopathological features (n)
|
p-S6
|
|---|
|
N
|
High (%)
|
Low (%)
|
P-value
|
|---|
|
Age (years)
|
|
≤ 50
|
95
|
48 (50.5)
|
47 (49.5)
| |
|
>50
|
255
|
121 (47.5)
|
134 (52.5)
|
0.632
|
|
Gender
|
|
Male
|
266
|
114 (42.9)
|
152 (57.1)
| |
|
Female
|
84
|
55 (65.5)
|
29 (34.5)
|
0.000a
|
|
Clinical stage
|
|
Stage I-II
|
151
|
75 (49.7)
|
76 (50.3)
| |
|
Stage III
|
199
|
93 (46.7)
|
106 (53.3)
|
0.519
|
|
LN status
|
|
LNM
|
210
|
117 (55.7)
|
93 (44.3)
| |
|
No LNM
|
140
|
52 (37.1)
|
88 (62.9)
|
0.001a
|
|
Histological type
|
|
SCC
|
154
|
47 (30.5)
|
107 (69.5)
| |
|
ADC
|
196
|
122 (62.2)
|
74 (37.8)
|
0.000a
|
|
Pathological grade
|
|
Well/ Moderate
|
152
|
77 (50.7)
|
75 (49.3)
| |
|
Poor
|
198
|
92 (46.5)
|
106 (53.5)
|
0.452
|
|
Survival status
|
|
Alive
|
187
|
77 (41.2)
|
110 (58.8)
| |
|
Dead
|
163
|
92 (56.4)
|
71 (43.6)
|
0.005a
|
- aChi-square test, statistically significant difference (P < 0.05). Abbreviations: ADC Adenocarcinoma, SCC squamous cell carcinoma, LNM Lymph node metastasis
